CAS RN: 1000787-75-6

5-((6-(2,4-bis(TrifluoroMethyl)phenyl)pyridazin-3-yl)Methyl)-2-(2-fluorophenyl)-5H-iMidazo[4,5-c]pyridine

Product Availability

Choose a grade to view its available package options.

1 package records1 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20251018 5mg / 10mg / 50mg Confirm by inquiry Shanghai, Shandong Inquiry
  • Product code: starshine_CAS1000787-75-6
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1000787-75-6 / 5-[[6-[2,4-bis(trifluoromethyl)phenyl]pyridazin-3-yl]methyl]-2-(2-fluorophenyl)imidazo[4,5-c]pyridine

Tegobuvir | 1000787-75-6 | 5-((6-(2,4-bis(Trifluoromethyl)phenyl)pyridazin-3-yl)methyl)-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine

Standard CAS: 1000787-75-6 Multi CAS: No

Basic Information

CAS
1000787-75-6
Multi CAS
No
Molecular Formula
C25H14F7N5
Molecular Weight
517.400000
Exact Mass
517.113743
SMILES
C1=CC=C(C(=C1)C2=NC3=CN(C=CC3=N2)CC4=NN=C(C=C4)C5=C(C=C(C=C5)C(F)(F)F)C(F)(F)F)F
InChI
InChI=1S/C25H14F7N5/c26-19-4-2-1-3-17(19)23-33-21-9-10-37(13-22(21)34-23)12-15-6-8-20(36-35-15)16-7-5-14(24(27,28)29)11-18(16)25(30,31)32/h1-11,13H,12H2
InChIKey
XBEQSQDCBSKCHJ-UHFFFAOYSA-N
Synonyms
Tegobuvir 1000787-75-6 5-((6-(2,4-bis(Trifluoromethyl)phenyl)pyridazin-3-yl)methyl)-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine GS-9190 GS-333126

Computed Properties

Structural Parameters

Heavy atom count
37
Aromatic heavy atom count
27
Fraction Csp3
0.12
Rotatable bonds
4
H-bond acceptors
5
Molar refractivity
118.61
TPSA
56.49

LogP / Solubility

WLOGP
6.73
MLOGP
5.96
XLogP3
4.7
Consensus LogP
5.8
Log S (ESOL)
-7.57
Class (ESOL)
Insoluble
Log S (Ali)
-8.66
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-9.09
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.1

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
5

Get In Touch

Contact Us